• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Candida auris 感染的分子特征和临床结局:沙特阿拉伯单中心经验。

Molecular characterisation and clinical outcomes of Candida auris infection: Single-centre experience in Saudi Arabia.

机构信息

Section of Infectious Diseases, Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

Department of Medicine, King Salman Armed Forces Hospital, Tabuk, Saudi Arabia.

出版信息

Mycoses. 2020 May;63(5):452-460. doi: 10.1111/myc.13065. Epub 2020 Mar 3.

DOI:10.1111/myc.13065
PMID:32072717
Abstract

BACKGROUND

Candida auris is a difficult-to-diagnose multidrug-resistant yeast that can cause invasive infections with high mortality. Since emerging in 2009, this pathogen has been associated with numerous outbreaks around the world. Whole genome sequencing (WGS) is instrumental for understanding the emergence and local transmission of this pathogen.

OBJECTIVES

To describe the clinical, molecular characteristics of Candida auris infection and clinical outcome in our centre.

PATIENTS AND METHODS

Patients with positive cultures for Candida auris were identified in a microbiology database. Clinical characteristics and antifungal susceptibility were obtained. Isolates were sent to the US CDC for whole genome sequencing.

RESULTS

Seven unique patients with eight different isolates were identified. Seven isolates were sent to the US CDC for whole genome sequencing. None of the patients had bloodstream infection. Thirty-day mortality was higher in infected patients compared with those who were colonised. Seven of the eight isolates were resistant to both fluconazole, and five were resistant to amphotericin B. WGS analysis demonstrated that the seven isolates belonged to the South Asian clade but formed two distinct subclades suggesting two independent introductions and ongoing transmission within the facility.

CONCLUSIONS

Candida auris is associated with a high mortality rate in infected patients. Strict infection control measures and surveillance for asymptomatic cases are warranted to halt ongoing transmission.

摘要

背景

耳念珠菌是一种难以诊断的多重耐药酵母菌,可导致死亡率很高的侵袭性感染。自 2009 年出现以来,这种病原体与世界各地的许多疫情有关。全基因组测序(WGS)对于了解该病原体的出现和本地传播至关重要。

目的

描述我们中心的耳念珠菌感染的临床、分子特征和临床结局。

患者和方法

从微生物数据库中确定了耳念珠菌阳性培养的患者。获得了临床特征和抗真菌药敏性。将分离株送往美国疾病控制与预防中心进行全基因组测序。

结果

共确定了 7 例具有 8 种不同分离株的独特患者。将 7 个分离株送往美国疾病控制与预防中心进行全基因组测序。没有患者发生血流感染。与定植患者相比,感染患者的 30 天死亡率更高。8 株分离物中有 7 株对氟康唑和两性霉素 B 均耐药。WGS 分析表明,这 7 株分离株属于南亚分支,但形成了两个不同的亚分支,提示在该设施内存在两次独立的传入和持续传播。

结论

耳念珠菌感染患者的死亡率很高。需要采取严格的感染控制措施和对无症状病例进行监测,以阻止持续传播。

相似文献

1
Molecular characterisation and clinical outcomes of Candida auris infection: Single-centre experience in Saudi Arabia.Candida auris 感染的分子特征和临床结局:沙特阿拉伯单中心经验。
Mycoses. 2020 May;63(5):452-460. doi: 10.1111/myc.13065. Epub 2020 Mar 3.
2
Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses.全基因组测序和流行病学分析证实三大洲同时出现多重耐药性耳念珠菌
Clin Infect Dis. 2017 Jan 15;64(2):134-140. doi: 10.1093/cid/ciw691. Epub 2016 Oct 20.
3
Emergence of the novel sixth Clade VI in Bangladesh.孟加拉国新型第六 Clade VI 的出现。
Microbiol Spectr. 2024 Jul 2;12(7):e0354023. doi: 10.1128/spectrum.03540-23. Epub 2024 Jun 6.
4
Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey.美国多重引入和随后传播的耐多药念珠菌:分子流行病学调查。
Lancet Infect Dis. 2018 Dec;18(12):1377-1384. doi: 10.1016/S1473-3099(18)30597-8. Epub 2018 Oct 4.
5
Multicenter Candida auris outbreak caused by azole-susceptible clade IV in Pernambuco, Brazil.巴西伯南布哥州由唑类药物敏感性 IV 分支引起的多中心耳念珠菌暴发。
Mycoses. 2024 Jun;67(6):e13752. doi: 10.1111/myc.13752.
6
Detection and characterisation of a sixth Candida auris clade in Singapore: a genomic and phenotypic study.在新加坡检测和表征第六个新型假丝酵母菌(Candida auris)菌株:一项基因组和表型研究。
Lancet Microbe. 2024 Sep;5(9):100878. doi: 10.1016/S2666-5247(24)00101-0. Epub 2024 Jul 13.
7
Risk factors, antifungal susceptibility, complications, and outcome of Candida auris bloodstream infection in a tertiary care center in the western region of Saudi Arabia.沙特阿拉伯西部地区一家三级护理中心的耳念珠菌血流感染的危险因素、抗真菌药敏性、并发症和结局。
J Infect Public Health. 2024 Jan;17(1):182-188. doi: 10.1016/j.jiph.2023.11.021. Epub 2023 Nov 23.
8
Development of Candida auris Short Tandem Repeat Typing and Its Application to a Global Collection of Isolates.开发耳念珠菌短串联重复序列分型及其在全球分离株中的应用。
mBio. 2020 Jan 7;11(1):e02971-19. doi: 10.1128/mBio.02971-19.
9
Molecular characterization of Candida auris outbreak isolates in Qatar from patients with COVID-19 reveals the emergence of isolates resistant to three classes of antifungal drugs.来自 COVID-19 患者的卡塔尔耳念珠菌爆发分离株的分子特征揭示了对三类抗真菌药物具有耐药性的分离株的出现。
Clin Microbiol Infect. 2023 Aug;29(8):1083.e1-1083.e7. doi: 10.1016/j.cmi.2023.04.025. Epub 2023 Apr 26.
10
Whole genome sequencing analysis demonstrates therapy-induced echinocandin resistance in Candida auris isolates.全基因组测序分析表明,耳念珠菌分离株对棘白菌素类药物的治疗产生了耐药性。
Mycoses. 2023 Dec;66(12):1079-1086. doi: 10.1111/myc.13655. Epub 2023 Sep 15.

引用本文的文献

1
A Comprehensive Review of Epidemiology, Risk Factors, Clinical Manifestations, Antifungal Susceptibility, and Mortality of Candida auris in Saudi Arabia.沙特阿拉伯耳念珠菌的流行病学、危险因素、临床表现、抗真菌药敏性及死亡率的综合综述
Cureus. 2025 Aug 5;17(8):e89455. doi: 10.7759/cureus.89455. eCollection 2025 Aug.
2
Epidemiology of Candidemia, Candiduria and Emerging Candidozyma (Candida) auris Across Gulf Cooperative Council Countries and Yemen in the Arabian Peninsula.阿拉伯半岛海湾合作委员会国家和也门念珠菌血症、念珠菌尿症及新兴耳念珠菌(假丝酵母菌属)的流行病学
Mycoses. 2025 Jun;68(6):e70073. doi: 10.1111/myc.70073.
3
The multidrug-resistant complex and phylogenetic related species: Insights into antifungal resistance mechanisms.
多重耐药复合体及系统发育相关物种:对抗真菌耐药机制的见解
Curr Res Microb Sci. 2025 Jan 28;8:100354. doi: 10.1016/j.crmicr.2025.100354. eCollection 2025.
4
Recurrent Fungemia Due to Candida auris.耳念珠菌引起的复发性真菌血症
Cureus. 2024 Jun 16;16(6):e62478. doi: 10.7759/cureus.62478. eCollection 2024 Jun.
5
Current Perspectives of Antifungal Therapy: A Special Focus on .抗真菌治疗的当前观点:特别关注于…… (原文不完整,翻译到这里截止)
J Fungi (Basel). 2024 Jun 6;10(6):408. doi: 10.3390/jof10060408.
6
Spectrum of infection and outcomes in individuals with Candida auris infection in Qatar.卡塔尔假丝酵母菌感染个体的感染谱和结局。
PLoS One. 2024 May 23;19(5):e0302629. doi: 10.1371/journal.pone.0302629. eCollection 2024.
7
The many faces of Candida auris: Phenotypic and strain variation in an emerging pathogen.耳念珠菌的多面性:一种新兴病原体的表型和菌株变异。
PLoS Pathog. 2024 Mar 1;20(3):e1012011. doi: 10.1371/journal.ppat.1012011. eCollection 2024 Mar.
8
Description of Occurrence in a Tertiary Health Institution in Riyadh, Saudi Arabia.沙特阿拉伯利雅得一家三级医疗机构中的发病情况描述。
Healthcare (Basel). 2023 Dec 12;11(24):3150. doi: 10.3390/healthcare11243150.
9
Outbreaks of Fungal Infections in Hospitals: Epidemiology, Detection, and Management.医院内真菌感染的暴发:流行病学、检测与管理
J Fungi (Basel). 2023 Oct 29;9(11):1059. doi: 10.3390/jof9111059.
10
Risk factors and mortality of the newly emerging in a university hospital in Saudi Arabia.沙特阿拉伯一家大学医院中新出现情况的风险因素及死亡率。
Mycology. 2023 Jun 29;14(3):256-263. doi: 10.1080/21501203.2023.2227218. eCollection 2023.